Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs geared toward expanding the horizons of cytokine-based immunotherapy, especially for cancers where treatment method options remain limited. Utilize the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Explore Our Pipeline https://financefeeds.com/nvidia-nvda-shares-edge-lower-after-earnings-report/